LABOCANNA S.A. ZY-10 Net Assets
LABOCANNA S.A. ZY-10 net assets. Based on the latest financial reports, LABOCANNA S.A. ZY-10 (9Y2) has net assets worth €2.83 Million EUR (≈ $3.31 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€9.53 Million ≈ $11.15 Million USD) and total liabilities (€6.70 Million ≈ $7.83 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 9Y2 net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.83 Million |
| % of Total Assets | 29.71% |
| Annual Growth Rate | -9.07% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3.05 |
Net Assets of LABOCANNA S.A. ZY-10 (2022–2025)
Net assets of LABOCANNA S.A. ZY-10 from 2022 to 2025. This chart illustrates how LABOCANNA S.A. ZY-10's net assets have evolved over time, based on quarterly financial data. See LABOCANNA S.A. ZY-10 (9Y2) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Net Assets for LABOCANNA S.A. ZY-10 (2022–2025)
The table below shows the annual net assets of LABOCANNA S.A. ZY-10 from 2022 to 2025. For live market cap and overall valuation, see LABOCANNA S.A. ZY-10 market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €5.72 Million ≈ $6.69 Million |
-13.20% |
| 2024-12-31 | €6.59 Million ≈ $7.70 Million |
-5.99% |
| 2023-12-31 | €7.01 Million ≈ $8.19 Million |
-7.87% |
| 2022-12-31 | €7.61 Million ≈ $8.89 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to LABOCANNA S.A. ZY-10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 207807349.0% over the analyzed period, potentially due to dividend distributions or operating losses.
LABOCANNA S.A. ZY-10 Net Assets Breakdown (December 2025)
LABOCANNA S.A. ZY-10 net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €11.42 Million | 200.42% |
| Total Equity | €5.70 Million | 100.00% |
LABOCANNA S.A. ZY-10 Competitors by Market Cap
The table below lists competitors of LABOCANNA S.A. ZY-10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tessin Nordic Holding AB
ST:TESSIN
|
$789.48K |
|
Veganz Group AG
F:VEZ
|
$792.16K |
|
Hotel Fast SSE AB (publ)
ST:MAXENT-B
|
$792.76K |
|
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
XETRA:EFF
|
$794.86K |
|
Shree Ram Proteins Limited
NSE:SRPL
|
$787.61K |
|
Europejskie Centrum Odszkodowań SA
WAR:EUC
|
$786.01K |
|
Eco Animal Health Group Plc
LSE:EAH
|
$779.50K |
|
Maven Income And Growth Vct 3 Plc
LSE:MIG3
|
$778.08K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LABOCANNA S.A. ZY-10's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,566,615 to 5,695,787, a change of -870,828 (-13.3%).
- Net loss of 872,549 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-872.55K | -15.32% |
| Other Changes | €1.72K | +0.03% |
| Total Change | €- | -13.26% |
Book Value vs Market Value Analysis
This analysis compares LABOCANNA S.A. ZY-10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.15x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | €0.36 | €0.04 | x |
| 2023-12-31 | €0.33 | €0.04 | x |
| 2024-12-31 | €0.31 | €0.04 | x |
| 2025-12-31 | €0.27 | €0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LABOCANNA S.A. ZY-10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -15.32%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -38.90%
- • Asset Turnover: 0.17x
- • Equity Multiplier: 2.36x
- Recent ROE (-15.32%) is below the historical average (-11.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -15.58% | -40428.72% | 0.00x | 1.16x | €-1.95 Million |
| 2023 | -8.54% | -3624.46% | 0.00x | 1.08x | €-1.30 Million |
| 2024 | -6.73% | -43.72% | 0.12x | 1.28x | €-1.10 Million |
| 2025 | -15.32% | -38.90% | 0.17x | 2.36x | €-1.44 Million |
Industry Comparison
This section compares LABOCANNA S.A. ZY-10's net assets metrics with peer companies in the Specialty Business Services industry.
Industry Context
- Industry: Specialty Business Services
- Average net assets among peers: $-24,809,818
- Average return on equity (ROE) among peers: 10.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LABOCANNA S.A. ZY-10 (9Y2) | €2.83 Million | -15.58% | 2.37x | $788.53K |
| ABL GROUP ASA NA NK-10 (26Q) | $99.45 Million | 4.38% | 0.87x | $102.68 Million |
| Cimpress plc (3UF) | $-407.48 Million | 0.00% | 0.00x | $1.54 Billion |
| CPPGroup Plc (4CV1) | $-26.00K | 0.00% | 0.00x | $4.37 Million |
| SG COMPANY S.P.A. (7KZ) | $5.16 Million | -5.01% | 5.52x | $6.80 Million |
| Bastogi S.p.A (BAOA) | $50.48 Million | -19.48% | 6.80x | $130.77 Million |
| STOCK3 AG NA O.N. (BOG) | $4.29 Million | 24.78% | 0.62x | $34.27 Million |
| Francotyp-Postalia Holding AG (FPH) | $30.05 Million | 16.95% | 3.73x | $47.81 Million |
| SSH GROUP LTD (JRSA) | $-5.80 Million | 0.00% | 0.00x | $8.73 Million |
| NorCom Information Technology GmbH & Co. KGaA (NC5A) | $582.49K | 73.58% | 7.86x | $2.79 Million |
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. It is also involved in commercial real estate management activities. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its … Read more